3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
23
Glioma
13
Astrocytoma
9
Brain Neoplasms
8
Neuroblastoma
6
Neoplasms
6
Gliosarcoma
6
Sarcoma, Ewing
4
Medulloblastoma
4
Rhabdomyosarcoma
3
Recurrence
3
Oligodendroglioma
3
Diffuse Intrinsic Pontine Glioma
3
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Spinal Cord Neoplasms
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
Imatinib Mesylate
4
Sunitinib
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
ripretinib
1
pemigatinib
1
Surgical Instruments
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Ipilimumab
1
IDRX-42
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Temozolomide
×
30 days
×
Clear all
No trials found.